Navigation Links
Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations
Date:9/23/2008

Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately.

Rye, NY (PRWEB) September 23, 2008 -- Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately. Dr. Zinberg will be responsible for the day-to-day management of Curemark as well as for the implementation of Curemark’s strategic plan.

“In addition to having an outstanding track record in the health care field, Dr. Zinberg brings a tremendous level of expertise, energy and business acumen to Curemark,” states Dr. Joan Fallon, Curemark’s CEO. “We are honored to have someone of Dr. Zinberg’s caliber as Curemark’s new Vice–President of Operations.”

Dr. Zinberg was previously the Chief Operating Officer of a privately held multi-million dollar health care corporation, The Masters Circle. The Masters Circle provides consulting services to the health care sector within the United States and internationally.

“As Curemark is preparing to enter clinical trials for its proprietary drug for autism, Dr. Zinberg joins us at a most historic time,” states Dr. Matthew Heil, Vice-President for Drug Development and Manufacturing for Curemark. “She will help lead us into the next phases of our company development, and implementation of our strategic plan for our vast array of clinical targets.”

Curemark is a biotechnology company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company’s initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon. The company is currently preparing for clinical trials. To learn more about our innovative science, please visit: www.cure-mark.com.

Media Contact:
Alissa Minio
info @ cure-mark.com
(914) 925-3450

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1366754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
2. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
3. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
4. Millennium Pharmacy Systems, Inc. Appoints New CEO
5. National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry:
6. U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board
7. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
8. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
9. Cadient Group Appoints Andrew le Blanc as Creative Director
10. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
11. Sonic Innovations Appoints New President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
(Date:2/23/2017)... This report analyzes analyzes the worldwide markets for Wound Debridement Products ... the US, Canada , Japan ... , Latin America , and Rest ... period 2015 through 2022. Also, a six-year historic analysis is ... from primary and secondary research. Company profiles are primarily based ...
Breaking Medicine Technology: